Novavax Inc. Stock Underperforms Friday When Compared To Competitors

Wesco International Inc

Change company Symbol lookup

Select an option...

WCC Wesco International Inc

TNP-F Tsakos Energy Navigation Ltd

ANEB Anebulo Pharmaceuticals Inc

NCA Nuveen California Municipal Value Fund

SGOL abrdn Physical Gold Shares ETF

GAB-K Gabelli Equity Trust Inc

GAB-H Gabelli Equity Trust Inc

GAB-G Gabelli Equity Trust Inc

AAL American Airlines Group Inc

ARKF ARK Fintech Innovation ETF

Industrials : Trading Companies & Distributors | Mid Cap Blend

Company profile

WESCO International, Inc. is a provider of business-to-business distribution, logistics services and supply chain solutions. The Company conducts its business through three segments: Electrical & Electronic Solutions (EES), Communications & Security Solutions (CSS) and Utility & Broadband Solutions (UBS). The EES segment supplies a range of products and solutions primarily to the construction, industrial and original equipment manufacturer (OEM) markets. Its EES segment supplies various products, including electrical equipment and supplies, automation and connected devices (the Internet of Things), security, lighting, wire and cable, safety, and maintenance, repair and operating (MRO) products. Its CSS segment operates in the network infrastructure and security markets. The UBS segment provides products and services to investor-owned utilities, public power companies, including municipalities, as well as global service providers, wireless providers and broadband operators.

Novavax Inc. Stock Underperforms Friday When Compared To Competitors

5:15 pm ET February 3, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Novavax Inc. (NVAX) slipped 6.49% to $11.23 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 1.59% to 12,006.95 and Dow Jones Industrial Average falling 0.38% to 33,926.01. The stock's fall snapped a three-day winning streak. Novavax Inc. closed $90.16 below its 52-week high ($101.39), which the company reached on February 7th.

The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) fell 0.56% to $164.61, Pfizer Inc. (PFE) fell 0.63% to $44.06, and Merck & Co. Inc. (MRK) fell 0.50% to $102.94. Trading volume (6.5 M) remained 1.0 million below its 50-day average volume of 7.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled February 3, 2023.

(END) Dow Jones Newswires

February 03, 2023 17:15 ET (22:15 GMT)